Tevogen Bio
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $396 | $0 | $0 | $0 |
Gross Profit | 198 | -99 | ||
EBITDA | -9,385 | -5,652 | -8,599 | |
EBIT | -9,488 | -5,871 | -8,599 | |
Net Income | -9,444 | -9,444 | -5,884 | -9,663 |
Net Change In Cash | 396 | 0 | 0 | 0 |
Free Cash Flow | -3,047 | -3,047 | -3,804 | -2,982 |
Cash | 1,282 | 1,282 | 2,330 | 1,135 |
Basic Shares | 146,672 | 175,051 | 170,174 | 154,167 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | 188 | -953 | -28 |
EBIT | -8 | -1,183 | -38 |
Net Income | -67 | 4,408 | -15,596 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,376 | -694 | -5,384 |
Cash | 8 | 129 | 7,119 |
Basic Shares | 165,421 | 119,999 | 119,999 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.05 |
2024-09-30 | -$0.03 |
2024-06-30 | -$0.03 |
2024-03-31 | -$0.26 |
